INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication.
In a clinical trial, adding Rejoyn to antidepressant medication reduced depression symptoms with zero side effects related to Rejoyn.
Using Rejoyn for less than 2 hours per week for 6 weeks is designed to change how the brain works, which can improve depression symptoms.
Over the course of 6 weeks, Rejoyn delivers proven brain-training exercises and short skills-based therapy lessons.
If you feel that your depression symptoms are worsening or if you have feelings or thoughts of harming yourself or others, please contact your healthcare provider, dial 911, or go to the nearest emergency room immediately.